Hypothesis

Aging triggers low‑grade neuroinflammation that feeds back to the gut, reducing Clostridiales‑derived indole‑3‑propionic acid (IPA) synthesis. Lower IPA diminishes intestinal PXR activation, weakening tight‑junction protein expression (ZO‑1, Occludin) and increasing permeability. The resulting microbial translocation amplifies systemic inflammation, which further aggravates brain microglia activation, creating a self‑reinforcing loop that drives inflammaging.

Rationale

• IPA produced by gut Clostridiales activates intestinal PXR to upregulate barrier genes【https://pmc.ncbi.nlm.nih.gov/articles/PMC12375546/】.
• IPA crosses the BBB and suppresses neuroinflammation in AD models【https://www.science.org/doi/10.1126/sciadv.adw8410】.
• Germ‑free or Nr1i2^-/- mice lose both gut‑barrier and neuroprotective effects, proving microbiota‑PXR dependence【https://www.science.org/doi/10.1126/sciadv.adw8410】【https://pmc.ncbi.nlm.nih.gov/articles/PMC12375546/】.
• Centenarians maintain high fecal IPA, whereas unhealthy older adults show a decline【https://isappscience.org/insights-into-healthy-aging/】.
• Polyphenol‑rich diets raise serum IPA and correlate with Clostridiales abundance in elders【https://onlinelibrary.wiley.com/doi/full/10.1002/mnfr.202100349】. These data show IPA is a bidirectional messenger, but they do not test whether age‑related brain inflammation can suppress microbial IPA production.

Predictions

1. In conventionally housed aged wild‑type mice (18‑22 mo), hippocampal TNF‑α and Iba1‑positive microglial activation will be inversely correlated with fecal IPA concentrations.
2. Administering a broad‑spectrum antibiotic cocktail that depletes Clostridiales will mimic the aged phenotype in young mice, lowering fecal IPA, increasing gut permeability (FITC‑dextran serum), and elevating hippocampal inflammation.
3. Supplementing aged wild‑type mice with IPA will restore barrier integrity and reduce neuroinflammation only when the microbiota is intact and PXR is present; the same treatment will fail in germ‑free or Nr1i2^-/- hosts.
4. Conversely, inducing hippocampal inflammation via intracerebroventricular LPS in young mice will reduce Clostridiales abundance and fecal IPA within 48 h, preceding any detectable gut‑leakage.

Experimental Design

• Groups (n=10 per group): young (3 mo) vs. aged (20 mo) wild‑type; aged wild‑type + IPA (10 mg/kg/day oral); aged Nr1i2^-/-; aged germ‑free; young mice treated with antibiotic cocktail; young mice receiving intracerebroventricular LPS.
• Measurements (collected at baseline and after 4 weeks): fecal IPA (LC‑MS/MS), serum FITC‑dextran (permeability), colonic ZO‑1/Occludin (qPCR/IHC), hippocampal TNF‑α, IL‑1β, Iba1 morphology (confocal), blood LPS‑binding protein (endotoxemia).
• Analysis: Two‑way ANOVA (age × treatment) with post‑hoc tests; correlation analyses between fecal IPA and hippocampal inflammation markers.

Potential Outcomes

• Support: Aged wild‑type mice show low fecal IPA, high permeability, and neuroinflammation; IPA supplementation rescues both gut and brain phenotypes only in microbiota‑sufficient, PXR‑positive animals; inducing brain inflammation lowers IPA before gut leakage appears.
• Refutation: IPA levels remain unchanged with age or neuroinflammatory manipulations; IPA supplementation improves outcomes regardless of microbiota or PXR status; brain‑derived inflammatory signals do not alter Clostridiales abundance.

Implications

If confirmed, the hypothesis positions the microbiome not just as a source of protective metabolites but as a sensor of host neuroimmune state. Therapeutic strategies would need to combine microbiota‑targeted approaches (prebiotics, probiotics, polyphenols) with PXR‑modulating agents and anti‑inflammatory CNS interventions to break the vicious cycle of inflammaging.